These newest shots replace combination vaccines that mixed protection against the original coronavirus strain and even older omicron variants. That specific strain is no longer dominant but it's close enough to coronavirus strains causing most COVID-19 illnesses today that FDA determined it would offer good cross-protection. On May 12, 2021, CDC approved the use of the Pfizer-BioNTech COVID-19 vaccine in persons aged 12-15 years, following the vaccines EUA granted by the FDA on May. The newest shots target an omicron variant named XBB.1.5. Younger children might need additional doses depending on their history of COVID-19 infections and vaccinations. FDA said starting at age 5, most people can get a single dose even if they've never had a prior COVID-19 shot.
Just like earlier vaccinations, the fall round is cleared for adults and children as young as age 6 months. It's been a year since the last time the vaccines were tweaked. Vaccinations could begin later this week, and both the COVID-19 and flu shot can be given at the same visit.ĬOVID-19 hospitalizations have been rising since late summer although – thanks to some lasting immunity from prior vaccinations and infections – not nearly as much as this time last year.īut protection wanes over time and the coronavirus continually churns out new variants that can dodge prior immunity. 'I feel like healing is coming,' said New York nurse Sandra. A CDC advisory panel is set to issue recommendations Tuesday on who most needs the updated shots. The first Covid-19 vaccination in the United States has taken place, as the country gears up for its largest ever immunisation campaign.
There's still another step: The Centers for Disease Control and Prevention must sign off. It's part of a shift to treat fall updates of the COVID-19 vaccine much like getting a yearly flu shot. The Food and Drug Administration decision opens the newest shots from Moderna and Pfizer and its partner BioNTech to most Americans even if they've never had a coronavirus vaccination. approved updated COVID-19 vaccines Monday, hoping to rev up protection against the latest coronavirus strains and blunt any surge this fall and winter.
0 kommentar(er)
